Literature DB >> 16614148

Withdrawal of port-catheter system for hepatic arterial infusion chemotherapy implanted with fixed catheter tip method.

Takuji Yamagami1, Takeharu Kato, Tatsuya Hirota, Rika Yoshimatsu, Tomohiro Matsumoto, Tsunehiko Nishimura.   

Abstract

PURPOSE: To evaluate the feasibility and safety of a method to withdraw port-catheter systems implanted by the fixed catheter tip method.
MATERIALS AND METHODS: Retrospective review was conducted of 14 cases of unresectable advanced liver cancer in which it was necessary to attempt 15 withdrawals of percutaneously placed implantable port-catheter systems. Reasons for withdrawal, withdrawal success, complications, and subsequent treatment of patient were evaluated.
RESULTS: In 14 of the 15 procedures (93.3%), the port-catheter system was successfully retrieved. Because continuation of hepatic arterial infusion chemotherapy was necessary in 10 procedures, a second implantation was performed after withdrawal of the initial catheter. Only one complication occurred, in which the indwelling catheter was broken in the aorta during withdrawal.
CONCLUSION: When retrieval of a port-catheter system implanted with the fixed catheter tip method is necessary, withdrawal can be accomplished safely with high frequency.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16614148     DOI: 10.1097/01.RVI.0000208981.37434.5E

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  2 in total

1.  A simplified technique of percutaneous hepatic artery port-catheter insertion for the treatment of advanced hepatocellular carcinoma with portal vein invasion.

Authors:  Sun Young Choi; Ah Hyun Kim; Kyung Ah Kim; Jong Yun Won; Do Yun Lee; Kwang-Hun Lee
Journal:  Korean J Radiol       Date:  2010-10-29       Impact factor: 3.500

2.  Complications in hepatic arterial infusion chemotherapy: retrospective comparison of catheter tip placement in the right/left hepatic artery vs. the gastroduodenal artery.

Authors:  Rinpei Imamine; Toshiya Shibata; Ken Shinozuka; Kaori Togashi
Journal:  Surg Today       Date:  2017-02-10       Impact factor: 2.549

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.